Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022 Pharmaceutical Investing
Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange SmartNews
Albert Labs Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange Pharmaceutical Investing
NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments Psychedelics Investing
How Investing in Mental Health is an Investment in Combating Opioid Addiction Pharmaceutical Investing
Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research Pharmaceutical Investing
Seelos Therapeutics Receives an Acknowledgement Letter of a Clinical Trial Notification from the Australian Government Department of Health Therapeutic Goods Administration for a Pilot Study of SLS-005 in Alzheimer's Disease Psychedelics Investing
Universal Ibogaine Inc. to Webcast Live at OTC Markets VirtualInvestorConferences.com March 10th Pharmaceutical Investing
